Madrigal Pharmaceuticals
MDGL
#1827
Rank
NZ$19.64 B
Marketcap
NZ$865.15
Share price
1.17%
Change (1 day)
57.41%
Change (1 year)

Market capitalization of Madrigal Pharmaceuticals (MDGL)

Market cap: NZ$19.64 Billion

As of January 2026 Madrigal Pharmaceuticals has a market cap of NZ$19.64 Billion. This makes Madrigal Pharmaceuticals the world's 1827th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Madrigal Pharmaceuticals from 2007 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$19.64 B-16.34%
2025NZ$23.48 B93.96%
2024NZ$12.10 B67.64%
2023NZ$7.22 B-11.44%
2022NZ$8.15 B284.55%
2021NZ$2.12 B-10.99%
2020NZ$2.38 B14.17%
2019NZ$2.08 B-19.39%
2018NZ$2.58 B40.82%
2017NZ$1.83 B638.85%
2016NZ$0.24 B251.2%
2015NZ$70.86 M-80.8%
2014NZ$0.36 B-32.09%
2013NZ$0.54 B-28.09%
2012NZ$0.75 B155.18%
2011NZ$0.29 B-11.29%
2010NZ$0.33 B41.05%
2009NZ$0.23 B-33.83%
2008NZ$0.35 B20.72%
2007NZ$0.29 B

End of Day market cap according to different sources

On Jan 19th, 2026 the market cap of Madrigal Pharmaceuticals was reported to be:

NZ$19.64 Billion
by Nasdaq info icon info icon
NZ$19.64 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Onconova Therapeutics
ONTX
NZ$36.05 M-99.82%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
NZ$1.75 B-91.08%๐Ÿ‡บ๐Ÿ‡ธ USA